Oded Levy - 23 Jan 2024 Form 4 Insider Report for Cardio Diagnostics Holdings, Inc. (CDIO)

Reporting relationship: Director
Issuer ticker: CDIO
Reported as of: 23 Jan 2024
Net transaction value: +$50,000
SEC form: 4
Accepted by SEC: 21 Feb 2024, 17:57:14 UTC
Prior SEC filing: 02 Jan 2024
Next SEC filing: 08 Apr 2024
Source filing: View source filing
Reporting owner signature: /s/ Elisa Luqman as attorney-in-fact for Oded Levy

Key filing fact

Oded Levy filed Form 4 for Cardio Diagnostics Holdings, Inc. (CDIO) on 21 Feb 2024.

Key facts

This page summarizes Oded Levy's Form 4 filing for Cardio Diagnostics Holdings, Inc. (CDIO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 21 Feb 2024, 17:57.

Change

Previous filing in this sequence was filed on 02 Jan 2024.
Current net transaction value: +$50,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDIO transaction Derivative

Restricted Stock Units

Award

Transaction value: $50,000
Shares
Change %
Price
Shares after: $50,000
Date: 23 Jan 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: $50,000
Exercise price: $0.000000
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the RSU.

Footnote F2

Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on March 31, 2024; (ii) $12,500 in value on June 30, 2024; (iii) $12,500 in value on September 30, 2024; and (iv) $12,500 in value on December 31, 2024.

Footnote F3

The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.